CD1A and carcinoma: It has been speculated that a higher density of CD1a+ DCs in tumor tissue correlates with favorable clinical outcomes, and several studies have reported that tumor-infiltrating CD1a+ DCs were associated with favorable clinical outcomes in carcinomas of various organs [13–17].